These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and stability study of desloratadine multicomponent crystal formation. Ainurofiq A; Mauludin R; Mudhakir D; Soewandhi SN Res Pharm Sci; 2018 Apr; 13(2):93-102. PubMed ID: 29606963 [TBL] [Abstract][Full Text] [Related]
4. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574 [TBL] [Abstract][Full Text] [Related]
5. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors. An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645 [TBL] [Abstract][Full Text] [Related]
6. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Huang Y; Zhang Q; Wang JR; Lin KL; Mei X Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301 [TBL] [Abstract][Full Text] [Related]
7. [Co-amorphous technology to improve dissolution and physical stability of silybin]. Liu H; Zhao GW; Jiang QY; Liang XL; Ouyang LQ; Ding HB; Chen XL; Liao ZG Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):103-110. PubMed ID: 35178916 [TBL] [Abstract][Full Text] [Related]
8. Tannic acid as a co-former in co-amorphous systems: Enhancing their physical stability, solubility and dissolution behavior. Fael H; Demirel AL Int J Pharm; 2020 May; 581():119284. PubMed ID: 32243965 [TBL] [Abstract][Full Text] [Related]
10. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine. Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246 [TBL] [Abstract][Full Text] [Related]
11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
12. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study. Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. Andrews GP; AbuDiak OA; Jones DS J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine. Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670 [TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization and Prevention of Auto-oxidation of Amorphous Sirolimus by Encapsulation in Polymeric Films Using Hot Melt Extrusion. Kanaujia P; Poovizhi P; Ng WK; Tan RBH Curr Drug Deliv; 2019; 16(7):663-671. PubMed ID: 31038065 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
18. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods. Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805 [TBL] [Abstract][Full Text] [Related]
19. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters. Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874 [TBL] [Abstract][Full Text] [Related]
20. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions. Liu X; Zhou L; Zhang F Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]